StockStory.org on MSN
Why is PacBio (PACB) stock soaring today?
The previous big move we wrote about was 1 day ago when the stock dropped 3.1% on the news that the Trump administration's ...
Collaboration powers secure international data sharing through the HiFi Solves Global ConsortiumMENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s ...
The latest update pegs Pacific Biosciences of California’s fair value at US$2.50 per share, compared with the prior US$2.42 anchor, giving investors a fresh reference point for the story. Analysts are ...
Pacific Biosciences’ fourth quarter results exceeded Wall Street’s expectations, supported by record consumables revenue and robust instrument placements, particularly for the Revio and Vega ...
MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate ...
AZoLifeSciences on MSN
Retrotransposons and their role in human genetic disorders
Retrotransposons are pivotal in human genome evolution, driving structural variation and regulatory innovation while influencing health and disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results